Potential cancer drug likely to benefit asthmatic people
According to experts from the Edinburgh University, a potential cancer drug on trial, R-Roscovitine, can exacerbate symptoms associated with asthma in addition to killing certain immune cells.
It was revealed by the experts that the drug can prove its effectiveness for treating asthma who are resistant to asthma steroid treatment apart from treating cancer patients.
From News.bbc.co.uk:
The [...]
December 21, 2009 | Posted in Steroids Blog | Read More »

